Qingming Luo is the President of Hainan University, Haikou, China. He completed his undergraduate education in Technical Physics at Xidian University, Xi’an, China in 1986. He received M.Sc. degree in Optics and Ph.D degree in Physical Electronics from Huazhong University of Science and Technology (HUST).
In the early 90’s. Qingming went to work with the founder of biophotonics, the world-renowned Professor Britton Chance of the University of Pennsylvania. After returning to HUST, he immediately built one of the most comprehensive research centers in China in the area of biophotonics, which he named it as Britton Chance Center for Biomedical Photonics (BCCBMP). With an inherent understanding of the importance of scientific globalization, he established for the BCCBMP an intellectually intensive and progressive International Advisory Board, in which three members are Nobel laureates.
Recognizing his scientific vision, accomplishments as well as his comprehensive scientific administration skillsets, in 2007, he was appointed as Vice President of HUST, whose portfolio is to develop the scientific and technological endeavors of the university. In the same year, he was also appointed as the Executive Deputy Director of Wuhan National Laboratory for Optoelectronics (WNLO) affiliated with HUST, and became the Director in 2017. Under his leadership, Biomedical Engineering and Optical Engineering at HUST was ranked the FIRST in China Discipline Ranking in 2016.
In 2018, following the Central Government’s intention of building Hainan Province into one of China’s major Free Trade Port, and recognizing the fundamental importance of having a world-class research university as one of the engines of this endeavor, the Chinese Ministry of Education recommended Hainan Provincial Government appointing Qingming as president of Hainan University. Over the past five years, with his leadership, Qingming has been instrumental in transforming the university, both intellectually and administratively.
Recognizing Qingming’s contributions in the field of optical bioimaging and optical neuroscience, he was inducted as the Academician of the Chinese Academy of Sciences in 2019 and Chinese Academy of Medical Sciences in 2020. Furthermore, he is also elected to be the Fellow of the International Academy of Medical and Biological Engineering (IAMBE), the American Institute for Medical and Biological Engineering (AIMBE), Optica (formerly OSA), the Institution of Engineering and Technology (IET), the International Society for Optics and Photonics (SPIE) and Chinese Optical Society (COS).
To build world-class disciplinesTo develop HNU into a first-class university in China and even in the world
Serve the needs of national strategies and to contribute to Hainan FTP developmentFocus on seven major research fieldsGive full play to Hainan's advantages in natural resources, policies and application scenarios
To take the leading role through our irreplaceable contributions, our distinctiveness,our high threshold, and our adherence to opening up and innovation
Hainan University, aligning with national strategies and the major needs of Hainan Free Trade Port construction, focuses on high-quality development and actively plans and practices the "1443" strategic framework for creating the world-class disciplines and establishing a top-tier domestic university. "1" represents the strategic goal, referring to President Xi Jinping's address during the 30th anniversary of Hainan's establishment as a Special Economic Zone, emphasizing support for Hainan University to build the world-class disciplines. "4" signifies strategic positioning, as stated by the Provincial Party Secretary Shen Xiaoming during his special research visit, that Hainan University should find its role in the comprehensive deepening of Hainan's reforms and the construction of a Free Trade Port with Chinese characteristic, serving as participants, think tanks, incubators, and reserves. The next "4" symbolizes strategic thinking, adhering to the educational philosophy of "supportive leadership, characteristic success, high-level engagement, and open innovation". "3" indicates the strategic path, implementing "full credit system, collaborative innovation center, and all-member residential academy system" reforms.
Prof. Dr. Da Hsuan Feng was born in New Delhi, India, and grew up in Singapore. In 1968, Prof. Feng received a bachelor’s degree in physics from Drew University, and a Ph.D. in theoretical physics from the University of Minnesota in 1972. He then became for the next four years a postdoctoral fellow at the Department of Theoretical Physics of the University of Manchester and the Center for Nuclear Studies of the University of Texas at Austin. In 1976, he became a faculty member in the Physics Department of Drexel University in Philadelphia. From 1990 to 2000, he became the M. Russell Wehr Chair Professor of Physics at Drexel University. During his tenure at Drexel University, he also held appointments as Director of Theoretical Physics of the United States National Science Foundation, visiting professor of Niels Bohr Institute of the University of Copenhagen and United Kingdom Daresbury Laboratory. Feng was a consultant for three National Laboratories in the United States, namely Los Alamos, Oak Ridge and Brookhaven and UK’s Daresbury Laboratory.
Currently, Prof. Feng is the Chief Advisor of China Silk iValley Research Institute, the top 6 among China’s 600 Think-Tanks, the Honorary Dean of Hainan University Belt and Road Research Institute, and a Senior Fellow of Singapore’s Nanyang Technological University’s Institute of Advanced Studies. He was bestowed a Fellow of the American Physical Society and serves as an honorary/guest professor of 15 Chinese universities. Prof. Feng has published over 180 refereed papers in nuclear physics, nuclear astrophysics, quantum optics, and mathematical physics. He was the editor of twenty conference proceedings books, presenting numerous invited talks in International Conferences. He received the Bian-Zhong Award for Hubei Province in 2009 and the “The Light of Civilization, the 2017 Chinese Cultural Exchange Award”.
Dr. Carter Tseng is currently the CEO of the Little Dragon Foundation and Executive Chairman of the Nankai International Business Forum. After graduating with a B.Sc. in electrical engineering from Taiwan University in 1970, Dr. Tseng earned his master’s, and doctoral degrees in Computer Science and Electronics Engineering from UCLA in 1973 and 1976.
Dr. Tseng was a co-founder of Microtek in 1980, the world-class leader in the Image Scanner industry. Since retiring from active corporate management in 1998, Dr. Tseng has drawn on his rich experience and turned his attention to coaching and mentoring the CEOs of tomorrow, as well as serving on the advisory boards of many enterprises. Now, he is a Director of the USA-based “Committee of 100” and Board of Trustee of Give2Asia Foundation and an economic consultant to Tianjin, Chengdu and Shenzhen Municipal People’s Government. He is also the special advisor to Tsinghua University President, and EMBA & CEO Training Professor. His academic posts include Adjunct Professorships at the City University of Hong Kong, the University of Alberta (Canada), Nankai University, Sichuan University, and so on.
Dr. Tseng received the “2004 Distinguished Achievement Award” from CIE (Chinese Institute of Engineers, USA) and the National Friendship Award from the central government of China.
Boasting a doctoral degree in Law from the University of Texas, Howard Chen, Esq. is now a Shareholder of Greenberg Traurig Law Firm, San Francisco, U.S.A. As the Co-Chair of the Firm's China Practice, he advises international companies doing business in Asia and the United States on intellectual property strategies, licensing negotiation, and litigation arising from intellectual property disputes. With deep knowledge of the business environment in China and strong relationships among Asia-based enterprises, Howard understands the cultural and business objectives of companies involved in cross-border transactions and litigation matters. He is also on the executive committee of ChinaSF, an organization supporting investment in the San Francisco Bay Area by enhancing the interaction between Chinese companies and the San Francisco business community. In Managing IP Magazine's World IP Handbook and Survey, Howard Chen was listed as an “IP Stars: Patent Stars” for 2018-2020.
Ms. Olivia Ho Cheng received her master’s degree in Economics from UCLA and her bachelor’s degree from Taiwan Chengchi University. She has served as CEO of Aurora Healthcare Corp, a Massachusetts medical technology and global healthcare company, for more than 10 years (since 2003). Aurora was a spin-off from an MIT research project in the late 1990s, when a group of MRI elite engineers committed to finding a solution using MRI technology to better breast cancer detection. Now, Aurora has developed the only FDA cleared dedicated MRI system specifically designed for detecting and diagnosing breast cancer.
Prior to leading Aurora, Olivia has nearly 20 years of commercial and investment banking experience, including being a high-ranking Dedicated Authority Lender for the Export-Import Bank of the United States, one of the members of the White House Export Committee, and a board member of Accuray Inc., Kenneth B. Schwartz Center, Tufts University School of Medicine, Britton Chance Center for Biomedical Photonics National Laboratory at Huazhong University of Science & Technology, and the U.S. – China Health Summit.
Prof. Jing Cheng is a member of the Chinese Academy of Engineering and the International Eurasian Academy of Sciences. He is also a winner of the National Science Fund for Distinguished Young Scholars, and a member of the Chang Jiang Scholars Program of the Ministry of Education. Currently, Dr. Cheng is a chair professor and doctoral supervisor at the Department of Biomedical Engineering, School of Medicine, Tsinghua University, director of the National Engineering Research Center (Beijing) for Biochip Technology, and chairman and president of CapitalBio Corporation.
Prof. Cheng graduated from Tongji University with a bachelor’s degree in engineering in 1983. From 1983 to 1986, he worked as an assistant engineer in the Diesel Engine Branch, Ziyang Internal Combustion Locomotive Factory, Ministry of Railways. From 1986 to 1999, while being designated as an assistant engineer and researcher at the Forensic Science Identification Center of Southwest University of Political Science and Law, Prof. Cheng studied at the University of Strathclyde in the UK between 1989 and 1992 and obtained a doctoral degree in Forensic Sciences. He later continued with postdoctoral research on molecular biology and biochip technology at the University of Aberdeen in the UK and the University of Pennsylvania in the US. Prof. Cheng held the position of research assistant professor at the Department of Pathology and Laboratory Medicine, School of Medicine, University of Pennsylvania, principal investigator at the U.S. Nanogen Inc., and chief technology officer of Aviva Biosciences Corp from 1996 to 2000. He began to teach at Tsinghua University after his return to China in March 1999.
Additionally, Prof. Cheng serves as a corresponding editor of Human Mutation, editorial board member of IET Nanobiotechnology, convenor of the seventh discipline review group on biomedical engineering of the Academic Degrees Committee of the State Council, chairman of the National Technical Committee for Biochip Standardization, vice chairman of the Chinese Society of Biomedical Engineering, chairman of the Medical Equipment Committee of the China Instrument and Control Society as well as member of the advisory board on national bio-industry development of the National Development and Reform Commission. Besides, Prof. Cheng has long been engaged in biotechnology research related to basic medicine, preventive medicine and clinical medicine, and has made significant contributions and innovations in biochip research.
Prof. Dr. Shu Chien is a world-renowned physiologist and bioengineer. His work on the fluid dynamics of blood flow has had a major impact on diagnosing and treating cardiovascular diseases such as atherosclerosis. Prof. Chien completed his medical preparatory study at Peking University Medical School from 1947 to 1948, and graduated from Taiwan University in 1953. He went to study in the United States in 1954 and obtained his Ph.D. in 1957 from Columbia University. From 1969 to 1988, Chien served as a Professor of Physiology and Biophysics at Columbia University. Chien became President of the Whitaker Institute of Biomedical Engineering at UCSD in 1991, a Founding Fellow of the American Institute for Medical and Biological Engineering in 1992, and the Chair of the Department of Bioengineering of UCSD from 1994 to 1999 and from 2002 to 2005. He was also the founding director of the Institute of Engineering in Medicine in July 2008. What’s more, Chien has served as President of the Biomedical Engineering Society, Microcirculatory Society, American Institute for Medical and Biological Engineering, American Physiological Society, International Society of Biorheology, Chinese American Medical Society and Chinese American Academic and Professional Association, etc.
Prof. Chien is one of a very small number of scholars who are members of all four national academies in America: the American Academy of Arts and Sciences, the National Academy of Engineering, the National Academy of Medicine, and the National Academy of Sciences. Prof. Chien is also a member of the National Academy of Inventors, and a foreign member of the Chinese Academy of Sciences and the Chinese Academy of Engineering. He was named a recipient of the National Medal of Science by President Barack Obama on September 27, 2011 for "pioneering work in cardiovascular physiology and bioengineering".
Prof. Dr. Aaron Ciechanover is an Israeli biologist and one of Israel's first Nobel Laureates in Science. He shared the Nobel Prize in Chemistry in 2004 with Avram Hershko and Irwin Rose for characterizing the method that cells use to degrade and recycle proteins using ubiquitin.
He earned a master's degree in science in 1971 and graduated from Hadassah Medical School in Jerusalem in 1974. He received his doctorate in biochemistry in 1981 from the Technion–Israel Institute of Technology before conducting postdoctoral research at the Whitehead Institute at MIT from 1981 to 1984.
Prof. Ciechanover is currently a Technion Distinguished Research Professor in the Ruth and Bruce Rappaport Faculty of Medicine and Research Institute at the Technion. He is a member of the Israeli National Academy of Sciences and Humanities, the European Molecular Biology Organization (EMBO), the American Philosophical Society, the Pontifical Academy of Sciences at the Vatican, and a foreign member of the Chinese Academy of Sciences, the Russian Academy of Sciences, the American Academy of Arts and Sciences, the National Academies of Sciences (NAS) and Medicine (NAM) of the USA.
Prof. Dr. Bill S. Hansson serves as Director of the Department of Evolutionary Neuroethology, Max Planck Institute for Chemical Ecology and a professor of Chemical Ecology. He is a Fellow of the African Academy of Sciences, and an Honorary Fellow of the Royal Entomological Society. He is also a foreign member of the Chinese Academy of Sciences, and an elected member of the Academia Europaea, the Royal Swedish Academy of Sciences, the Royal Swedish Academy of Agriculture and Forestry, the German National Academy of Sciences Leopoldina, and the Finnish Society of Sciences and Letters. Prof. Hansson’s research focuses on neurophysiological and behavioral aspects of interactions between insects and their host plants.
Prof. Hansson studied biology at Lund University where he received a Bachelor of Science degree in Biology in 1982. In 1988, he defended his Ph.D. thesis in Ecology. From 1989-1990, he worked as a postdoc at the University of Arizona and returned in 1990 to a junior professorship in Lund. In 1992, he became Associate Professor, and from 2000 until 2001, he was a Professor of Chemical Ecology at Lund University. From 2001 to 2006, he was Professor and Head of the Chemical Ecology Department at the Swedish University of Agricultural Sciences (SLU) in Alnarp, Sweden, until he was appointed Director and Scientific Member at the Max Planck Institute for Chemical Ecology in Jena, Germany in 2006. From 2014 until 2020, he served as Vice-President of the Max Planck Society.
Prof. Dr. Michael Levitt is an American-British-Israeli-South African biophysicist and a professor of structural biology at Stanford University, a position he has held since 1987. Levitt was elected a member of the European Molecular Biology Organization (EMBO) in 1983, a Fellow of the Royal Society (FRS) in 2001, and a member of the National Academy of Sciences in 2002 and the American Academy of Arts & Sciences in 2010, and received the 2013 Nobel Prize in Chemistry, together with Martin Karplus and Arieh Warshel, "for the development of multiscale models for complex chemical systems".
Prof. Levitt spent 1963 studying applied mathematics at the University of Pretoria. He attended King's College London, graduating with a first-class honors degree in Physics in 1967. Levitt was a Ph.D. student in Computational Biology at Gonville and Caius College, Cambridge, and was based at the Laboratory of Molecular Biology from 1968 to 1972, where he developed a computer program for studying the conformations of molecules that underpinned much of his later work.
In 1979, he returned to Israel and conducted research at the Weizmann Institute of Science in Rehovot. In 1986, he began teaching at Stanford University. From 1980 to 1987, he was a Professor of Chemical Physics at the Weizmann Institute of Science, Rehovot. Thereafter, he served as a Professor of Structural Biology at Stanford University, California.
Zhiping Song, an expert in corporate operation and management, serves as the Chairman of the China Association for Public Companies (CAPCO) and the China Enterprise Reform and Development Society. He was also the Chairman of the China National Building Material Group and the China National Pharmaceutical Group. Additionally, he is a visiting professor at the University of Jinan, the honorary dean of the School of Management at Wuhan University of Technology, a distinguished professor of management practice of the Guanghua School of Management at Peking University, and a visiting professor of management practice of the School of Economics and Management at Tsinghua University. Chairman Song has pioneered and implemented a series of business management models such as “Running Central Enterprises Based on Market-Oriented Rules”, “Integration and Optimization”, “Grid Control”, “Eight Major Management Methods”, and “Three Refined Management Techniques”. He has received numerous awards and honors, including the “Yuan Baohua Enterprise Management Gold Award”, “2018 Top 10 Economic Personages of China”, “Chinese Business Leaders Annual Award”, “The China Securities Golden Bauhinia Award for Most Influential Leader”, and “The Fortune China Business Person of the Year”.
Prof. Dr. Gregory C. Chow has been a major figure in econometrics and applied economics. He serves as Professor of Economics and Class of 1913 Professor of Political Economy, Emeritus, at Princeton University. He attended Cornell University (B.A., 1951) and the University of Chicago (M.A., 1952, and Ph.D., 1955). He was an Assistant Professor at MIT (1955-1959), an Associate Professor at Cornell University (1952-1962), a Research Staff member and Manager of Economic Research at the IBM Thomas J. Watson Research Center (1962-1970), and Professor of Economics and Director of the Econometric Research Program at Princeton University (1970-1997). In 2001, the Program was renamed the Gregory C. Chow Econometric Research Program in his honor.
He was a Visiting Professor at Cornell University in 1964, at Harvard University in 1967, and at Rutgers University in 1969, and from 1965 to 1971 he served as an Adjunct Professor of Economics at Columbia University. Prof. Chow is a member of the American Philosophical Society and a Fellow of the American Statistical Association and the Econometric Society. His publications include fourteen books and over 200 articles. In 2017, Prof. Chow was awarded the China Economics Prize.
Prof. Dr. A. Stephen Dahms is the Emeritus Distinguished Professor of Chemistry, Biochemistry, and Molecular Biology at San Diego State University and UC San Diego. He is also a member of the National Research Council, the National Academy of Engineering, and the National Academy of Medicine’s Roundtable on Biomedical Engineering Materials and Applications. He currently serves as the Consulting Vice President (Academic, Industry, and Government Affairs) of the Southern California Biomedical Council (SoCalBio), a trade organization for the Greater LA Region’s over 900 bioscience companies.
Prof. Dahms received his bachelor’s degree in chemistry from the College of Saint Thomas in 1965, and his Ph.D. in biochemistry from Michigan State University in 1969. During 1969-1972, he worked as a postdoctoral Research Fellow at UCLA. He has been an Emeritus Professor of Biochemistry/Chemistry at San Diego State University since 1972, and President/CEO Emeritus of Alfred E. Mann Foundation for Biomedical Engineering since 2006.
His past positions include: Executive Director of the California State University Program for Education and Research in Biotechnology (1985-2006), Director of the SDSU Molecular Biology Institute (1974-1991), and Director of the SDSU Center for Biopharmaceutical and Biodevice Development (1994-2006).
Prof. Dr. B. R. Deepak, a renowned Indian sinologist and translator, currently serves as a professor and the Chairperson at the Center of Chinese and Southeast Asian Studies, Jawaharlal Nehru University, New Delhi, India. Prof. Deepak earned his bachelor’s, master’s, and doctoral degrees from Jawaharlal Nehru University in 1989, 1991, and 1998 respectively. He has been a visiting fellow at the University of Edinburgh, UK, and the Chinese Academy of Social Sciences, Beijing China, and has delivered lectures at the Free University of Berlin, Bonn University, University of Heidelberg, Shanghai Academy of Social Sciences, Beijing Foreign Studies University, Sichuan University, and Harbin Normal University.
His areas of interest and specialization focus on India-China relations, Chinese studies, and translation. His publications include My Tryst with China: ‘Our’ Footprints on the Sands of Time (2017), India and China: Foreign Policy Approaches and Responses (2016), India-China Relations: Civilizational Perspective (2012), India-China Relations: Future Perspectives (2012), China: Agriculture, Countryside and Peasants (2010), India and China 1904-2004: A Century of Peace and Conflicts (2005), India-China Relations in the first half of the Twentieth Century (2001), Conficius Sukti Sangrah (The Analects of Confucius) (2016), and Cheeni Kavita: Gayarvin Shatavdi se Chuahdvin Shatavdi Tak (Chinese Poetry: 1100 BC to 1400 AD) (2010), a translation of 88 selected classical poems for which he was awarded the 2011 “Special Book Prize of China”.
Chairman of the board, David Group, Macau, China.
To help Hainan Province and HNU introduce more high-caliber talent and to support HNU in establishing world-class disciplines and its development into a leading university in China, Hainan David Investment Co., Ltd. signed a donation agreement with HNU in August 2018 to promote the establishment of Magnolia Scholar Support Program. This program is for HNU to reward outstanding talent who has made outstanding contributions to the University. In 2020, Hainan David Investment Co., Ltd. donated 50 million yuan to HNU for the Mulan Scholars Award Program. The first batch of winners is Professors Zhou Weimin and his wife Tang Lingling, Zou Ligang, Zhou Yongcan and Huang Mengxing, with one million yuan for each.
Academician Chunfang Lu, born in Lixian County of Hebei Province in China, is an expert in railway engineering technology and management. He received a bachelor’s degree from Southwest Jiaotong University in 1982, and a master’s degree from Tsinghua University in 2007. Now, he is the Chairman of the China Railway Society, and has served as Vice Minister of the former Ministry of Railways of the People’s Republic of China, Vice General Manager of the China State Railway Group Co., Ltd., and Chief Commander of China’s Qinghai-Tibet and Beijing-Shanghai High-speed Railways Construction Projects.
Academician Lu has been long engaging in railway construction management and technology innovation, and was the de facto organizer of China’s high-speed railway construction from 2005 to 2016. Under his leadership, the backbone of China’s high-speed railway network has been gradually established. Moreover, he has created a standardized and dynamic pattern to manage the high-speed railway construction. The CRTS III ballastless track system designed by Academician Lu has been widely used across China, and the “Fuxing Hao” (EMU), which was also invented by Lu, is automatic, systematic, and easy to operate. He received the Special Prize of the National Award for Scientific and Technological Progress in 2015, and was elected a member of the Chinese Academy of Engineering in 2017.
Prof. Dr. Mohamed Ibrahim bin Abdul Mutalib is the Vice Chancellor and President of Universiti Teknologi Petronas, Malaysia. Currently, he is a Fellow of Akademi Sains Malaysia, a Fellow with IChemE, UK, as well as holding a Chartered Engineer status with the UK Engineering Council.
He was a graduate of the University of New South Wales, Sydney, Australia with a Bachelor of Engineering (Hons) in Chemical Engineering, and earned his master’s and doctoral degrees at the University of Manchester Institute of Science and Technology (UMIST) in 1990 and 1995.
At the national level, he was involved in the development of the Programme Standard for Engineering and Technology Programme for Malaysian Qualifications Agency in 2012 which is used as the standard for national accreditation for all universities. In addition to his academic and research commitments, he has also served as an evaluator for the Engineering Accreditation Council, Malaysia for the accreditation of B.Eng. programmes in line with the Washington Accord. Due to his immense contribution, he had the privilege of working as a Reviewer with numerous groups including the National Research Grant Schemes such as IRPA, E-Science, FRGS and TechnoFund.
Internationally, he has been invited to become a committee member of several international conferences as well as a plenary speaker at several of them. In line with this, he has also added to his growing commitments the focus to review several reputable journals in the field of Chemical Engineering such as Industrial Engineering & Chemistry Research, The Canadian Journal of Chemical Engineering, and ASEAN Journal of Chemical Engineering. Not to mention that he was being invited and appointed to be a reviewer for the Qatar National Research Foundation Grant.
Prof. Dr. Erwin Neher is a German biophysicist, specializing in the field of cell physiology. He received his Master of Science degree from the University of Wisconsin – Madison in 1967, and a doctoral degree in physics from Munich Technical University in 1970. He worked as a Research Associate at Yale University from 1975 to 1976, earned a habilitation in physics at the University of Göttingen in 1981, and has been a Research Associate at the Max Planck Institute for Biophysical Chemistry since 1972, and Director and Scientific Member at the MPI for Biophysical Chemistry since 1983. He turned into an Emeritus Director of the Institute in 2011. He is also a Professor Emeritus at the University of Göttingen and a co-chair of the Bernstein Center for Computational Neuroscience Göttingen.
In 1986, he was awarded the Louisa Gross Horwitz Prize from Columbia University together with Prof. Bert Sakmann. In 1987, he received the Gottfried Wilhelm Leibniz Prize of the Deutsche Forschungsgemeinschaft, which is the highest honor awarded in German research. Along with Bert Sakmann, he was awarded the Nobel Prize in Physiology or Medicine in 1991 for "their discoveries concerning the function of single ion channels in cells".
Prof. Dr. Lihong Wang received his bachelor’s and master’s degrees in optics engineering from Huazhong University of Science & Technology in 1984 and 1987 respectively, and a doctoral degree from Rice University in Houston, Texas. Prof. Wang is the Bren Professor of Medical Engineering and Electrical Engineering at the Andrew and Peggy Cherng Department of Medical Engineering at California Institute of Technology and was formerly the Gene K. Beare Distinguished Professorship of Biomedical Engineering at Washington University in St. Louis. He is a Fellow of the American Association for the Advancement of Science (AAAS), American Institute for Medical and Biological Engineering (AIMBE), Electromagnetics Academy, International Academy of Medical and Biological Engineering (IAMBE), Institute of Electrical and Electronics Engineers (IEEE), the Optical Society of America (OSA), and Society of Photo-Optical Instrumentation Engineers (SPIE). Wang was elected as a member of the National Academy of Engineering in 2018 and a fellow of the National Academy of Inventors in 2020.
Prof. Wang is renowned for his contributions to the field of Photoacoustic imaging technologies and for inventing the world's fastest camera with more than 10 trillion frames per second. His research focuses on biomedical imaging. In particular, his lab has developed photoacoustic imaging that allows peering noninvasively into biological tissues. Compared to conventional optical microscopy, his techniques have increased the penetration by nearly two orders of magnitude, breaking through the optical diffusion limit. The Wang lab has invented or discovered functional photoacoustic tomography, 3D photoacoustic microscopy, optical resolution photoacoustic microscopy, photoacoustic Doppler effect, compressed ultrafast photography, and so on.
Prof. Fujia Yang is a Chinese nuclear physicist, an Academician of the Chinese Academy of Sciences and the International Eurasian Academy of Sciences, as well as a Fellow of the World Academy of Sciences. He obtained a degree in physics from Fudan University in 1958. After graduation, he became a lecturer, and later a professor of physics at Fudan, serving as President of the university from 1994 to 1999. Prof. Yang was Director of the Shanghai Institute of Nuclear Research of the Chinese Academy of Sciences from 1987 to 2001, Chairman of the Shanghai Science and Technology Association from 1992 to 1996, and the first president of the Association of University Presidents of China from 1997 to 1999.
Prof. Yang has held visiting professorships at the Niels Bohr Institute in Denmark, Rutgers University in the U.S., the State University of New York at Stony Brook in the U.S., and the University of Tokyo in Japan. He holds honorary degrees from Soka University of Japan, the State University of New York, the University of Hong Kong, the University of Nottingham in England, and the University of Connecticut in the U.S.
Prof. Yang was installed as the University of Nottingham's sixth Chancellor on July 4, 2001, the first time that a Chinese academic has become Chancellor of a UK university. In 2004, Yang was one of the 3 prime movers behind the creation of the University of Nottingham Ningbo China – along with Sir Colin Campbell and Madame Xu Yafen. On July 17, 2022, Prof. Fujia Yang died of illness in Shanghai at the age of 86.
Mr. Baoyong Zheng is Senior Vice President and Chief Scientist for Huawei Technologies Co., Ltd., a leading global provider of information and communications technology (ICT) infrastructure and smart devices in China. He received his bachelor’s and master’s degrees from Huazhong University of Science & Technology in 1984 and 1987 respectively. After graduation, he was committed to teaching and research at HUST until 1989 when he was transferred to Huawei serving as Chief Engineer and Executive Vice President. During his tenure at Huawei, Mr. Zheng headed the research and development of Huawei key projects such as subscriber switches, large-scale office digital switches, optical transmission, wireless mobile communication, and intelligent networks and he has won the State Scientific and Technological Progress Award for several times.
Mr. Zheng retired from Huawei in September 2009 and then he was appointed as an adviser by China Telecom and two state-owned enterprises. In 2013, he returned to Huawei as Senior Vice President and Chief Scientist, involved in strategic research on the Corporate and the development and research of new IT technologies and products.
Mr. Zheng was also an adjunct professor or visiting professor at the MIT Sloan School of Management, UCLA Anderson School of Management, Tsinghua University, Huazhong University of Science & Technology, University of Science and Technology of China and other well-known universities both at home and abroad. He is currently an adjunct professor at Shanghai Jiao Tong University, Xiamen University, Tongji University, Shanghai University and Shanxi Datong University.
Prof. Dr. Ada E. Yonath is an Israeli crystallographer best known for her pioneering work on the structure of the ribosome. She is the current director of the Helen and Milton A. Kimmelman Center for Biomolecular Structure and Assembly of the Weizmann Institute of Science. She graduated from the Hebrew University of Jerusalem with a bachelor's degree in chemistry in 1962, and a master's degree in biochemistry in 1964. In 1968, she obtained her PhD from the Weizmann Institute of Science for X-ray crystallographic studies on the structure of collagen. Yonath accepted postdoctoral positions at Carnegie Mellon University (1969) and MIT (1970).
In 1970, she established the first protein crystallography laboratory in Israel. Then, from 1979 to 1984, she was a group leader at the Max Planck Institute for Molecular Genetics in Berlin. She was a visiting professor at the University of Chicago in 1977–1978. She headed a Max-Planck Institute Research Unit in Germany (1986–2004) in parallel to her research activities at the Weizmann Institute.
In 2009, Yonath received the Nobel Prize in Chemistry for her studies on the structure and function of the ribosome, becoming the first woman in 45 years to win the Nobel Prize for Chemistry. With the approval by the Office of the State Council Academic Degrees Committee of China, it is with great honor that Hainan University will bestow Prof. Yonath the Doctor of Science, honoris causa, in recognition of her remarkable achievements in the science field and the academic exchange and cooperation between China and Israel.